Skip to content
Varieties from the European CatalogueGrown in FranceSlow dryingDispatched within 24 working hours — before noonEU delivery — 24-72 hRight of withdrawal — 14 daysCertificate available — per batch

ECS modulator (research)

Unscheduled

4-NPBA4-nonylphenylboronic acid

acide (4-nonylphényl)boronique

Aliases.4-nonylphenylboronic acid · acide para-nonylphénylboronique · 4-NPBA

A boronic acid inhibiting FAAH at 9.1 nanomolar, about 870 times selective over MAGL.

Updated on

Level of detail

Harm-reduction warning

No characterised human dose: animal / in vitro data only. Effect profile, safety margin and acute toxicity are not documented in human clinical practice. Extremely potent compound: severe effects, seizures and deaths reported in the literature.

Identifiers

Formula
C₁₅H₂₅BO₂
Molar mass
248.17 g·mol⁻¹
CAS
256383-45-6
PubChem CID
4589192
Origin
A wholly synthetic compound. Arylboronic acids are very widely used organic chemistry reagents, notably for cross-couplings, and this one was available as a catalogue product before being recognised as an enzyme inhibitor. It has no natural occurrence and no human use.
InChIKey
VONVJOGSLHAKOX-UHFFFAOYSA-N

In plain terms

4-nonylphenylboronic acid blocks the enzyme that destroys anandamide, and it does so very efficiently. Its distinctive feature is having been found by chance in a catalogue of chemistry reagents rather than designed for the purpose. It is a laboratory tool.

Receptors and activity

  • FAAH
    IC50 = 9,1 nM (Minkkilä et coll. 2008)Antagonist
  • MAGL
    IC50 = 7,9 µM ; sélectivité d'environ 870 fois pour la FAAHAntagonist
  • Agonist
  • Partial agonist
  • Antagonist
  • Modulator
  • Inverse agonist

Hover over a row for the precise value (Ki, EC50…)

Subjective signature

Hover over an axis to read its definition.

  • Calm
    20
  • Clarity
    10
  • Sleep
    15
  • Appetite
    10
  • High
    10

Editorial estimate, not clinical.

Pharmacology

4-nonylphenylboronic acid owes its entry into endocannabinoid pharmacology to a screening approach rather than to design work. Minkkilä and colleagues assessed in 2008 a series of commercial boronic acids, phenylic, heteroarylic, alkylic and alkenylic, for inhibition of the two enzymes that degrade the endocannabinoids. The general result was that these compounds preferentially inhibit fatty acid amide hydrolase, with effective concentrations ranging from the nanomolar to the low micromolar, and that eight of them also touch monoacylglycerol lipase in the micromolar range. The most potent proved to be the phenylboronic acid bearing a nonyl chain at the para position, with a median inhibitory concentration of 9.1 nanomolar at the amide hydrolase against 7.9 micromolar at monoacylglycerol lipase, that is a selectivity of about 870 times. The mechanism rests on a general property of boron. Electron-deficient, it accepts the lone pair of the catalytic serine and forms a tetrahedral adduct that reproduces the geometry of the transition state of the hydrolysis reaction, which constitutes a reversible but very tight inhibition, distinct from the irreversible covalent mechanism of the carbamates and ureas. That work founded the boronic acids as a class of amide hydrolase inhibitors and was extended by later work on boronic acids directed at other lipases, notably endothelial lipase.

Origin (research tool)

An entirely chemical route, described here by class only. The molecule combines a benzene ring bearing a linear nonyl chain at the para position with a boronic acid function. The boron atom, electron-deficient, is the functional element: it forms with the catalytic serine of hydrolases a tetrahedral adduct that mimics the transition state of the enzymatic reaction.

Structural classification

Class
ECS modulator (research)
Origin
A wholly synthetic compound. Arylboronic acids are very widely used organic chemistry reagents, notably for cross-couplings, and this one was available as a catalogue product before being recognised as an enzyme inhibitor. It has no natural occurrence and no human use.
Status
Unscheduled

References

  1. 1.Minkkilä et coll. 2008 : découverte des acides boroniques comme inhibiteurs puissants de la FAAHPMID 18983140

Structured data

InChIKey
VONVJOGSLHAKOX-UHFFFAOYSA-N
SMILES
B(C1=CC=C(C=C1)CCCCCCCCC)(O)O
Formula
C15H25BO2
Molar mass
248.17 g·mol⁻¹
CAS
256383-45-6
PubChem CID
4589192
Machine-readable entry (JSON)

LLM ingestion format: a structured superset of the entry (identifiers, binding, versioned legal status). Full corpus.